Navigation Links
Boehringer Ingelheim Enrolls First Patients in Pivotal Phase 3 Interferon-Free Hepatitis C Trial Program
Date:1/17/2013

d to announce that the first patients are now enrolled in our Phase 3 HCVerso™ program, including at U.S. trial sites," said Peter Piliero , M.D., Vice President, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc. "Patients infected with HCV may benefit most from an individualized treatment approach since a person's genetics, type of virus, and stage of liver disease vary from patient to patient. Our investigational interferon-free regimen has shown particular promise in treating patients with HCV genotype-1b so we have decided to enroll these patients in our Phase 3 trial program. Our goal is for an interferon-free future and ensuring patients are treated with the most effective treatment for them individually."

Results from the SOUND-C2 study, which were presented in November 2012 at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), found that up to 85 percent of patients infected with HCV GT-1b treated with Boehringer Ingelheim's investigational IFN-free regimen of faldaprevir, BI 207127 and ribavirin achieved viral cure at 12 and 24 weeks following treatment completion (SVR12 and SVR24).

Eliminating injectable interferon from treatment regimens is a critical goal in HCV as it can be difficult for patients to take due to long treatment duration and often severe side-effects. In addition, up to 50 percent of patients may not be eligible for treatment with interferon. Severe side-effects of interferon include heart failure, sepsis, leukopenia, depression and vision loss, resulting in adherence problems and treatment failure for many patients. Since 1999 there has been a significant increase in deaths due to chronic HCV, accounting for 15,000 deaths in the United States in 2007 alone.

"More effective and tolerable alternatives to interferon would help patients with their decision to start and
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boehringer Ingelheim Presents New Phase II Data for Volasertib in Adult Patients with AML
2. Boehringer Ingelheim Announces Equine Research Awards
3. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
4. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
5. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
6. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
7. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
8. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
9. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
10. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
11. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 17, 2015 /CNW/ - The issue: ... voluntarily recalling one lot (lot 710535) of Clavulin-400 (70mL) after ... had been found in one bottle of the  product. No ... time. Clavulin-400 is an oral antibiotic used in ... various bacterial infections. Clavulin-400 comes as a powder in bottles ...
(Date:4/17/2015)... 2015 Contego Medical, the first and ... platform for angioplasty balloon and stent delivery catheters, ... B financing round led by Hatteras Venture Partners, ... on medical devices, biopharmaceuticals, diagnostics and related opportunities ... Group Partners, Lookout Capital and Medical Mutual. ...
(Date:4/17/2015)... 2015  Regulatory leaders in the pharmaceutical industry continue ... called "21 st Century Cures." ... up by Congress soon and if enacted into law, ... are developed and marketed in the United ... begun to consider how the proposed changes could impact ...
Breaking Medicine Technology:Advisory - Clavulin-400 liquid oral antibiotic: One lot recalled after glass pieces found in one bottle 2Contego Medical Closes $5.6 Million in Series B Funding 2Contego Medical Closes $5.6 Million in Series B Funding 321st Century Cures: A Regulatory Game-Changer for the Pharmaceutical Industry 2
... Inc. (Nasdaq: TRBN ) today announced financial results ... 30, 2009. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090320/TRUBIONLOGO ) , ... , Revenue for the third quarter and nine ... $12.8 million, respectively, compared with $3.8 million and $12.2 ...
... Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be presenting at ... on Wednesday, November 11, 2009 at 10:00 a.m. PT / ... finance and chief financial officer at Amylin Pharmaceuticals, will be ... presentation will be webcast and a recording will be made ...
Cached Medicine Technology:Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 2Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 3Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 4Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 5Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 6Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 7
(Date:4/18/2015)... NE (PRWEB) April 18, 2015 ... in healthcare staffing, including physical therapy jobs, has ... at the South Carolina Physical Therapy Association Annual ... the Kroc Center in Greenville, SC. , ... opportunities, and exhibits with products and services. ...
(Date:4/18/2015)... ArcAngel ” was featured on NewsWatch as part of its ... coolest applications on the market for iOS, Android, ... expert, conducted the app review and shared with viewers how ... turbulent world, people may find themselves in dangerous situations where ... move, but some situations can be avoided if there was ...
(Date:4/18/2015)... PHOENIX, ARIZONA – In March, Mark ... other secure destruction professionals across the United States, earned ... will now display “CSDS” as a professional title with ... National Association of Information Destruction 2015 Annual Conference began ... Of the 20 people who took the exam, Ona ...
(Date:4/18/2015)... Canada (PRWEB) April 18, 2015 French ... emotions on food choices when he uttered, “Tell me ... you are.” Using food to cope with stress or ... by Queendom.com indicates otherwise. Data collected from ... genders fall victim to emotional eating, but for different ...
(Date:4/17/2015)... April 18, 2015 Heritage Woods of ... its Supportive Living Week Celebration on April 20 with ... a healthy mind, body and soul. , The community, ... Illinois, serves older adults of all incomes, including those ... independence. , Supportive Living Week is observed every April ...
Breaking Medicine News(10 mins):Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the South Carolina Physical Therapy Association Annual Conference 2Health News:A Personal Safety Application was Featured on NewsWatch Television 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3
... Association won a critical victory in our fight for ... of Appeals for the District of Columbia told the ... and reconsider their 2006 decision on the national ambient ... in partnership with its environmental colleagues and states had ...
... Farm in Lykens, Dauphin County, has tested negative for ... on Feb. 24, Agriculture Secretary Dennis Wolff said today. ... Pennsylvania farms selling raw milk must be permitted ... to the health risks associated with consuming the unpasteurized ...
... Herbalife Ltd. (NYSE: HLF ), a ... M.D., of Venezuela, to its Nutrition Advisory Board.The nutrition ... world in the fields of nutrition and health who ... sales employees, on the principles of nutrition, physical activity ...
... up for spring, the winter storms that left many ... situations can occur without warning. To ensure that we ... Health Association,s (APHA) "Get Ready: Set Your Clocks, Check ... preparedness kits when they change their clocks on March ...
... long-term risk of disease recurrence and deaths in premenopausal ... tamoxifen, according to trial data reported in the February ... National Cancer Institute. , Systematic reviews have shown ... risk of disease recurrence and death due to breast ...
... Doctors who become addicted to alcohol and other ... medical practice with the help of special programs ... rapid responses to noncompliance, University of Florida researchers ... analysis of such Physician Health Programs, and confirms ...
Cached Medicine News:Health News:American Lung Association Victory in Lawsuit Against EPA Gives New Opportunity to Protect Public Health From Deadly Air Pollutant 2Health News:Venezuelan Kidney Expert Joins Herbalife's Nutrition Advisory Board 2Health News:Check Your Emergency Stocks When You Change Your Clocks, Says APHA 2Health News:Goserelin improves long-term survival in premenopausal women with early breast cancer 2Health News:Treating drug-addicted doctors is good medicine 2Health News:Treating drug-addicted doctors is good medicine 3
Opti-One multi-purpose solution with citrate protein removal and advanced surfactant combination....
Light weight adjustable trial frame, adult...
Classic Trial Frames UB3 that has long set the standard....
Non Sterile surgical blade....
Medicine Products: